Global Clinical Trial Supplies Market, By Services (Storage, Manufacturing, Packaging and Labelling and Distribution), Clinical Phase (Phase III, Phase II, Phase IV, Phase I), Therapeutic Uses (Oncology, Cardiovascular Diseases, Dermatology, Metabolic Disorders, Infectious Diseases, Respiratory Diseases, CNS and Mental Disorders, Blood Disorders, Others), End User (Contract Research Organizations, Pharmaceutical and Biotechnology Companies) – Industry Trends and Forecast to 2031.
Clinical Trial Supplies Market Analysis and Size
In the clinical trial supplies market, the integration of blockchain technology ensures transparent and secure supply chain management, while AI-driven forecasting optimizes inventory management. RFID tagging enhances real-time tracking, reducing errors and enhancing efficiency. These advancements transform the industry, streamlining processes and ensuring regulatory compliance.
Data Bridge Market Research analyses that the global clinical trial supplies market, which was USD 3.53 billion in 2023, is expected to reach USD 6.74 billion by 2031, and is expected to undergo a CAGR of 8.4% during the forecast period of 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Services (Storage, Manufacturing, Packaging and Labelling and Distribution), Clinical Phase (Phase III, Phase II, Phase IV, Phase I), Therapeutic Uses (Oncology, Cardiovascular Diseases, Dermatology, Metabolic Disorders, Infectious Diseases, Respiratory Diseases, CNS and Mental Disorders, Blood Disorders, Others), End User (Contract Research Organizations, Pharmaceutical and Biotechnology Companies)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Movianto (U.S.), Sharp Services, LLC (U.S.),Thermo Fisher Scientific Inc.,(U.S.), Catalent, Inc (U.S.), PCI Pharma Services (U.S.), Almac Group (U.K.), PAREXEL International Corporation (U.S.), Bionical Emas (U.K.), Alium Medical Limited (U.K.), Myonex (U.K.), Clinigen Limited (U.K.), Ancillare, LP (U.S.), SIRO Clinpharm Private Limited (India), Clinigen Clinical Supplies Management (U.S.), Biocair (U.K.)
|
|
Market Opportunities
|
|
Market Definition
Clinical trial supplies refer to the materials and equipment essential for conducting medical research on new treatments or interventions. These supplies encompass medications, placebos, medical devices, and ancillary items required for the trial's execution. Ensuring timely and accurate provision of these resources is critical for the integrity and success of the trial.
Global Clinical Trial Supplies Market Dynamics
Drivers
- Growing Biopharmaceutical Industry Create Demand
As the biopharmaceutical sector expands, especially in biologics and modified medicine, there is a surge in demand for clinical trial supplies to facilitate research and development efforts. This heightened demand underscores the crucial role of efficient supply chains in enabling the advancement of innovative therapies and improving patient outcomes in healthcare.
- Rising Prevalence of Chronic Diseases Create Demand for Clinical Trial
The surge in chronic diseases such as cancer, cardiovascular issues, and autoimmune disorders intensifies the demand for clinical trials to pioneer new treatments. This heightened need for innovative therapies directly fuels the demand for clinical trial supplies, underlining their pivotal role in advancing medical research and addressing evolving healthcare challenges.
Opportunities
- Focus on Patient-Centric Trials for Improved Trial Experiences
Clinical trials increasingly prioritize patient needs, employing customized supply strategies for convenience, compliance, and retention. Direct-to-patient delivery and mobile health tech play vital roles, enhancing accessibility and engagement. Patient-centric approaches drive improved trial experiences, fostering greater participation and data accuracy for enhanced medical research outcomes.
- Advancements in Technology to Enhance the Efficiency of Clinical Trial Supply Operations
Technological advancements in supply chain management, packaging, and temperature-controlled logistics enhance the efficiency, accuracy, and safety of clinical trial supply operations. This drives adoption among pharmaceutical companies and contract research organizations (CROs), facilitating streamlined processes and ensuring compliance with regulatory requirements.
Restraints/Challenges
- Growing Concern of Data Security and Privacy
The growing concern over data security and privacy is particularly pertinent in the global clinical trial supplies market. With the sensitive nature of patient data and the criticality of maintaining confidentiality, ensuring robust security measures is imperative. Breaches in data security not only jeopardize patient privacy but also undermine the integrity and reliability of clinical trial results.
- Growing Complexity of Trial Designs
The rise of complex trial designs such as adaptive or basket trials complicates demand forecasting and inventory management in the clinical trial supplies market. This complexity increases the risk of overstocking or shortages, leading to inefficient resource allocation and potentially higher charges, thus hampering market efficiency and profitability.
This global clinical trial supplies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global clinical trial supplies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Developments
- In 2022, Thermo Fisher Scientific partnered with Medidata to enhance patient enrollment speed and clinical site selection, optimizing clinical trial planning and execution. This collaboration leverages datasets from 26,000 trials and 8 million patients worldwide, contributing to the evolving clinical trial supplies market
- In 2021, Thermo Fisher Scientific acquired PPD, Inc., a major clinical research services provider, for $17.4 billion, assuming PPD's net debt of approximately $3.0 billion. This acquisition significantly impacted the clinical trial supplies market, broadening Thermo Fisher's portfolio and global reach
- In 2020, Catalent, Inc. launched FlexDirect clinical supply services, offering pharmacy-to-patient and site-to-patient distribution alongside standard clinical supplies delivery. This hybrid approach caters to diverse sponsor needs, driving growth in the clinical trial supplies market through enhanced service customization and efficiency
- In 2020, Almac Clinical Services launched Tempod 1000, aimed at streamlining temperature logging processes in clinical settings. This digital solution improves patient safety and aligns with best practices, contributing to the evolution of digital technologies within the clinical trial supplies market
Global Clinical Trial Supplies Market Scope
The global clinical trial supplies market is segmented on the basis services, clinical phase, therapeutic uses and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Services
- Storage
- Manufacturing
- Packaging and Labelling
- Distribution
Clinical Phase
- Phase III
- Phase II
- Phase IV
- Phase I
Therapeutic Uses
- Oncology
- Cardiovascular Diseases
- Dermatology
- Metabolic Disorders
- Infectious Diseases
- Respiratory Diseases
- CNS and Mental Disorders
- Blood Disorders
- Others
End User
- Contract Research Organizations
- Pharmaceutical
- Biotechnology Companies
Global Clinical Trial Supplies Market Regional Analysis/Insights
The global clinical trial supplies market is analysed and market size insights and trends are provided by country, services, clinical phase, therapeutic uses and end user as referenced above.
The countries covered in the global clinical trial supplies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the clinical trial supplies market, holding significant market share and revenue. Its continued dominance is attributed to major key players and a well-developed healthcare infrastructure, ensuring sustained growth throughout the forecast period.
Asia-Pacific region is expected to exhibit the highest growth rate in the clinical trial supplies market, attributed to the expanding patient pool, escalating investments in healthcare, and robust government backing. This surge underscores the region's pivotal role in advancing clinical research and pharmaceutical development.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The global clinical trial supplies market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global clinical trial supplies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global clinical trial supplies market. The data is available for historic period 2016-2021.
Competitive Landscape and Global Clinical Trial Supplies Market Share Analysis
The global clinical trial supplies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global clinical trial supplies market.
Some of the major players operating in the global clinical trial supplies market are:
- Movianto (U.S.)
- Sharp Services, LLC (U.S.)
- Thermo Fisher Scientific Inc.,(U.S.)
- Catalent, Inc (U.S.)
- PCI Pharma Services (U.S.)
- Almac Group (U.K.)
- PAREXEL International Corporation (U.S.)
- Bionical Emas (U.K.)
- Alium Medical Limited (U.K.)
- Myonex (U.K.)
- Clinigen Limited (U.K.)
- Ancillare, LP (U.S.)
- SIRO Clinpharm Private Limited (India)
- Clinigen Clinical Supplies Management (U.S.)
- Biocair (U.K.)
SKU-